source
- Pfizer's Albert Bourla says he has no mega-merger plansThe most candid man in pharma strikes again. When asked on Tuesday’s earnings call whether Pfizer would consider a “transformative M&A” deal in the near or medium term, CEO Albert Bourla said it wo…Endpoints · 2mo ago↗ source
- HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI ResistancePhase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.onclive · 2mo ago↗ source
- BioNTech to scale down manufacturing, over 1,800 jobs on the lineBioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downs…